Physalis peruviana
What's the taxonomical classification of Physalis peruviana?
Physalis peruviana belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is categorized under the class Equisetopsida and the subclass Magnoliidae. Moving further down the taxonomic hierarchy, it is a member of the order Solanales and falls within the family Solanaceae. Finally, the plant is identified by its specific genus, Physalis, and its unique species designation, peruvianana.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Solanaceae |
| Genus | Physalis |
| Species | peruviana |
What are the morphological characteristics of this plant?
Physalis peruviana has perennial herbaceous stems that branch extensively to support clusters of bell-shaped, pale yellow flowers and fleshy, orange-to-red berries enclosed within a persistent, papery calyx. The leaves are typically ovate or elliptical with slightly serrated margins and a soft, pubescent texture. Each plant produces distinctive inflated husks that protect the developing fruit from environmental stressors and predators. These protective structures eventually dry into a lightweight shell as the fruit reaches full maturity. The root system consists of a robust rhizomatous structure that allows the plant to spread through its local habitat.
What is the geographical distribution of this plant?
This plant is native to the Andean regions of South America, specifically occurring within the territories of Peru, Ecuador, and parts of Colombia. It thrives primarily in high-altitude tropical environments where the climate remains cool and moist. These botanical specimens are frequently found growing along mountain slopes and in temperate valleys throughout the central cordillera. Because it is adapted to such specific elevations, its natural range is restricted to these unique montane ecosystems. The plant's distribution is closely tied to the presence of volcanic soil and consistent seasonal rainfall patterns.
How is this plant cultivated?
This plant Physalis peruviana grows best in well-drained, sandy loam soil under full sun exposure within warm temperate or tropical climates.
Growers must ensure the soil maintains consistent moisture without becoming waterlogged to prevent root rot. Because the plant is susceptible to various fungal diseases, providing adequate spacing for airflow is a crucial management practice. As the fruit develops inside its characteristic papery husk, it requires protection from pests like birds and rodents.
Harvesting should occur once the berries are fully colored and the husks have turned brown and dry.
What parts of this plant are used medicinally?
This plant Physalis peruviana is utilized medicinally through its aerial parts, fruit, leaves, roots, and stems. The edible fruit is most commonly consumed for its high vitamin content and antioxidant properties. Medicinal preparations often involve the leaves and stems to address various inflammatory conditions. Extracts from the roots are also studied for their potential therapeutic effects in traditional practices. Together, these diverse plant components provide a wide range of bioactive compounds used in holistic healing.
According to a study published by "Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health", the aerial parts of Physalis peruviana were used to isolate three new withanolides, physaperuviin G (1), physaperuviins I-J (2-3), and four known withanolides, namely, 4β-hydroxywithanolide E (4), withaperuviin C (5), physalactone (6), and coagulin (7). Additionally, two known compounds, phyperunoide F (8) and withanolide S (9), were isolated and identified from the poha berry fruits. All isolated poha compounds from the aerial parts and fruits were evaluated for anti-inflammatory activity using LPS-activated murine macrophage RAW 264.7 cells and TNF-α-activated NF-κB with transfected human embryonic kidney cells 293. The compound 4β-hydroxywithanolide E (4HWE) inhibited the growth of colon cancer monolayer and spheroid cultures. These studies also evaluated isolates for growth inhibitory effects against U251MG glioblastoma and MDA-MB-231 breast cancer cells. This research led to the filing of 3 provisional patents.
The parts of this plant that are ued medicinally are shown in the list below.
- aerial parts
- fruit
- leaf
- root
- stem
What traditional systems uses this plant?
This plant, known as Physalis peruviana or aguaymanto, has been utilized for centuries within Peruvian Traditional Medicine to treat various ailments including inflammation, respiratory issues, and digestive disorders. Indigenous communities in the Andes have historically relied on its nutrient-dense fruit and medicinal leaves to support general wellness and boost the immune system. Practitioners often prepare decoctions or infusions from different parts of the plant to alleviate pain or reduce fever in patients. Beyond its direct therapeutic applications, the plant holds a significant place in local dietary customs as a vital source of vitamins. These longstanding practices demonstrate a deep historical integration of the species into the cultural and medicinal fabric of the region.
According to a study published by "Natural product communications", there are an estimated 1400 plant species currently used in traditional Peruvian medicine. One of the species selected for this review is Physalis peruviana, which is also known as aguaymanto. The paper includes information regarding the traditional uses and current commercialization of Physalis peruviana. This plant is among the few that have undergone scientific investigation within the context of the review of botanical, chemical, pharmacological and clinical properties.
The hystorical systems that uses this plant are shown in the list below.
- Peruvian Traditional Medicine
What are the pharmacological activities of Physalis peruviana?
This plant has anti-cancer, anti-inflammatory, antioxidant, hepatoprotective, and immunomodulatory pharmacological activities. Its bioactive compounds help neutralize free radicals to prevent oxidative stress within the body. These properties also allow the plant to modulate immune responses and reduce harmful inflammation. Research indicates that specific extracts can protect liver cells from chemical damage and support overall organ health. Furthermore, certain constituents demonstrate potential in inhibiting the growth and spread of malignant cells.
According to a study published by "Molecular nutrition & food research", withanolides isolated from Physalis peruviana inhibit the growth of colon cancer monolayer and spheroid cultures. The specific compound 4β-hydroxywithanolide E (4HWE) inhibits growth in HT-29 cells at low concentrations by enhancing levels of p21(Waf1/Cip1) and inducing G0/G1 cell cycle arrest. At higher concentrations, 4HWE induces apoptosis and downregulates the levels of Hsp90 client proteins. This treatment increases nuclear sirtuin 1 (SIRT1) and decreases histone H3 acetylated at lysine 9. Furthermore, the expression of 21 genes is altered, which includes the downregulation of PTGS2 and correlates with reduced protein levels of cyclooxygenase-2 (COX-2).
The primary pharmacological activities of this plant are shown in the list below.
- anti-cancer
- anti-inflammatory
- antibacterial
- antimicrobial
- antioxidant
What medicinal compounds this plant contains?
This plant contains a diverse array of bioactive medicinal compounds including withanolides, physaperuviins, withaperuviin, physapruin A, and physalactone. These specific phytochemicals contribute to the plant's unique pharmacological profile and potential therapeutic applications. The withanolides are a key group of steroidal lactones known for their significant biological activities. Additionally, specialized constituents like physaperuviins and withaperuviin serve as important markers for its chemical identity. Researchers also study physapruin A and physalactone to better understand the plant's complex medicinal properties.
According to a study published by "Molecular nutrition & food research", Physalis peruviana contains withanolides that inhibit the growth of colon cancer monolayer and spheroid cultures. One specific compound isolated from the plant is 4β-hydroxywithanolide E (4HWE). Treatment of HT-29 cells with low concentrations of 4HWE inhibited growth and induced G0/G1 cell cycle arrest. At higher concentrations, 4HWE induced apoptosis. The expression of 21 genes was altered by this compound, including the downregulation of PTGS2.
The primary medicinal compounds of this plant are shown in the list below.
- 28-hydroxywithaperuviin C
- physalactone
- physaperuviin G
- withanolide J
- withaperuviin C
What health conditions is this plant used for?
This plant is used for treating arthritis, inflammation, liver damage, oxidative stress, and immune system dysfunction. Its bioactive compounds work to reduce swelling and pain associated with joint disorders. The plant also provides protective effects against hepatic injury by mitigating cellular damage in the liver. Furthermore, its antioxidant properties help the body combat harmful oxidative stress at a molecular level. These combined medicinal qualities can assist in regulating and supporting an unbalanced immune system.
According to a study published by "Journal of ethnopharmacology", Physalis peruviana fruit is used for its ethnomedical history in the treatment of arthritis. The research investigated its antiarthritic activity by assessing the inhibition of inflammatory mediators and its effect on rheumatoid arthritis (RA). An in vivo model of adjuvant-induced arthritis was used to trace serum TNFα, IL-1β, and IL-6. A high dose of extract (E-1000 mg) improved adjuvant-induced cachexia and attenuated immune-inflammatory responses with an equipotent effect to MTX. In silico evaluations of seven metabolites against the TNF-α target protein (PDB ID: 2AZ5) identified steroidal lactones with aperuvin E/C and hydroxywithanolide E as promising leads with docking scores of 6.301, 5.488, and 5.763 kcal/mol.
The main health conditions this plant is used for are shown in the list below.
- arthritis
- inflammation
- oxidative stress
- liver damage
- cancer
What are the herbal preparations of this plant?
This plant is used to create diverse medicinal preparations including a 12% ethanol extract, decoctions, concentrated extracts, fresh juice, and topical poultices. The 12% ethanol extract serves as a specialized solvent to pull specific bioactive compounds from the plant material. Practitioners often prepare a decoction by boiling the plant parts in water to extract soluble constituents for internal use. Liquid extracts and fresh juice provide concentrated doses of the plant's properties in a highly absorbable form. For external applications, a poultice is applied directly to the skin to deliver localized therapeutic benefits.
According to a study published by "Molecules (Basel, Switzerland)", the extraction of secondary metabolites from Physalis peruviana L. involved leaves, flowers, stems, and roots using water, MeOH:water (8:2) containing NaF, methanol, ethanol, and acetone (all diluted 7:3 in water). The study evaluated these parts through decoction and maceration methods to determine bioactive compound levels. The roots of Physalis peruviana L. showed important levels of total polyphenol content and flavonoids in consonance with the total antioxidant activity evaluated in the different organs. The extraction of these bioactive compounds was significantly determined by the specific solvents and extraction methods applied to the plant organs.
The main herbal preparations of this plant are shown in the list below.
- 12% ethanol extract
- decoction
- extracts
- juice
- poultice
What side effects this plant can have?
This plant can induce antiproliferative effects in various cell lines by triggering programmed cell death through apoptosis and autophagy. These biological mechanisms are often driven by the induction of endoplasmic reticulum stress within the targeted cells. Such cellular responses help to inhibit the rapid growth of abnormal tissues and promote the clearance of damaged components. However, prolonged or excessive cellular stress associated with these pathways could potentially contribute to the development of fibrosis in sensitive organs. Understanding these complex interactions is essential for determining the therapeutic safety profile of the species.
According to a study published by "International journal of molecular sciences", the withanolide Physapruin A (PHA) isolated from Physalis peruviana exerts antiproliferative effects on breast cancer cells such as MCF7 and MDA-MB-231. This substance induces significant ER expansion and aggresome formation in these specific cancer cells. PHA also upregulates the mRNA and protein levels of ER stress-responsive genes, namely IRE1α and BIP. When PHA is co-treated with the ER stress-inducer thapsigargin (TG), it demonstrates synergistic antiproliferation, reactive oxygen species generation, subG1 accumulation, and apoptosis via annexin V and caspases 3/8 activation. These observed ER stress responses and apoptosis changes are partly alleviated by the oxidative stress inhibitor N-acetylcysteine.
The main side effects this plant can have are shown in the list below.
- antiproliferative effects
- apoptosis
- autophagy
- endoplasmic reticulum stress
- fibrosis
What herbs are paired with Physalis peruviana?
This plant Physalis peruviana pairs effectively with citrus, mint, and ginger to enhance its unique sweet and tart flavor profile.
The bright acidity of lemon or lime juice complements the fruit's tropical undertones while balancing its natural sugar content. Fresh mint provides a refreshing herbal contrast that lightens the dense texture of the golden berries. Adding grated ginger introduces a subtle warmth and spice that deepens the overall complexity of the pairing.
These combinations are frequently utilized in gourmet desserts, infused waters, and sophisticated fruit salsas.